Skip to main content
. 2023 Feb 23;14:1133207. doi: 10.3389/fimmu.2023.1133207

Figure 3.

Figure 3

Immune-related pneumonitis in a 79-year-old male with stage IV non-small cell lung cancer in the left lower lobe. After second line treatment with nivolumab (anti-PD-1) (5 cycles), the patient developed progressive dyspnea and dry cough. Axial (A) and coronal (B) CT images demonstrate multifocal alveolar consolidations in a predominantly peribronchovascular and subpleural location compatible with a drug-induced pneumonitis.